obesity tirzepatide (ZEPBOUND) Approved for Chronic Weight Management in Adults with ✨ The FDA has approved Zepbound (tirzepatide) for chronic weight management in adults with obesity (BMI of 30 kg/ m2 or Bodybuilding to Obesity (~300lbs) to

pancreatitis, thyroid cancer, kidney injury, etc.) and hypoglycemia risk are comparable for semaglutide, dulaglutide, exenatide once weekly and liraglutide

Your side effect notes can include things such as: what dose of the drug you were taking when you had the side effect how soon you had the side effect after starting that dose what your symptoms were how your symptoms affected your daily activities what other medications you were taking any other information you feel is important Keeping notes and sharing them with your doctor will help them learn more about how Zepbound affects you

Realistic assessment matters here

Body maps: Print or draw a simple outline of the front and back of your body